These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24649797)

  • 21. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.
    Tanaka M; Yamazaki E; Chiba M; Yoshihara K; Akasaka T; Takemura M; Sato K
    Antimicrob Agents Chemother; 2002 Mar; 46(3):904-8. PubMed ID: 11850285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
    Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
    Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2003)].
    Goto H; Takeda H; Kawai S; Nakadate T; Shimada K; Nakano K; Suwabe A; Yokouchi H; Okada S; Ashino Y; Ikemoto H; Gejyo F; Igari J; Okada M; Oguri T; Aoki N; Mori T; Yamamoto M; Kitamura N; Inoue H; Suzuki Y; Karasawa Y; Tosaka M; Kudo K; Kobayashi N; Kohno S; Tanaka T; Hirakata Y; Kondo A; Matsuda J; Nakano M; Sumitomo M; Nasu M; Niki Y; Hiramatsu K; Suga M; Suzuki Y
    Jpn J Antibiot; 2005 Jun; 58(3):326-58. PubMed ID: 16161758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
    Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In-vitro susceptibilites to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M; Kanda M; Tsujio Y; Kimoto H; Kaimori M; Nakamura T; Kawamura C; Nishimura M; Akizawa K; Katayama Y; Matsuda K; Hayashi T; Yasujima M; Kasai T; Kimura M; Tominaga M; Miki M; Nakanowatari S; Nakagawa T; Kaku M; Kanemitsu K; Kunishima H; Toyoshima S; Sakurai M; Shiotani J; Sugita A; Ito T; Okada J; Suwabe A; Yamahata K; Yoneyama A; Kumasaka K; Yamane N; Koike K; Ieiri T; Kominami H; Yamada T; Oguri T; Itoh K; Watanabe K; Kobayashi Y; Ohtake T; Uchida T; Totsuka K; Murakami M; Yomoda S; Takahashi A; Okamoto H; Inuzuka K; Yamazaki K; Gonda H; Yamashita T; Yamaguchi I; Okada M; Ikari H; Kurosawa N; Fujimoto Y; Ishigo S; Asano Y; Mikio M; Kano I; Nagano E; Kageyama F; Shaku E; Kanno H; Aihara M; Gemma H; Uemura K; Miyajima E; Maesaki S; Hashikita G; Horii T; Sumitomo M; Yoshimura H; Hiraoka M; Wada H; Yuzuki Y; Ikeda N; Baba H; Soma M; Yamamoto T; Ichiyama S; Kinosita S; Kawano S; Fujita S; Kageoka T; Hongo T; Okabe H; Tatewaki K; Moro K; Oka M; Niki Y; Yoshida H; Yamashita M; Kusano N; Mihara E; Nose M; Fushiwaki T; Kuwabara M; Fujiue Y; Shimuzu A; Takubo T; Kusakabe T; Hinoda Y; Tanaka N; Takahashi H; Heijyou H; Okazaki T; Asai K; Kawahara K; Masuda J; Sano R; Taminato T; Negayama K; Matsuo S; Komatsu M; Sugiura T; Murase M; Hiramatsu K; Yamane N; Nakasone I; Hirakata Y; Kohno S; Aizawa H; Honda J; Hamazaki N; Okayama A; Ono J; Aoki Y; Okada K; Miyanohara H
    Jpn J Antibiot; 2006 Dec; 59(6):428-51. PubMed ID: 17334061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E; Dalhoff A; Korfmann G
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007].
    Yamaguchi K; Ohno A; Ishii Y; Tateda K; Iwata M; Kanda M; Akizawa K; Shimizu C; Kon S; Nakamura K; Matsuda K; Tominaga M; Nakagawa T; Sugita A; Ito T; Kato J; Suwabe A; Yamahata K; Kawamura C; Tashiro H; Horiuchi H; Katayama Y; Kondou S; Misawa S; Murata M; Kobayashi Y; Okamoto H; Yamazaki K; Okada M; Haruki K; Kanno H; Aihara M; Maesaki S; Hashikita G; Miyajima E; Sumitomo M; Saito T; Yamane N; Kawashima C; Akiyama T; Ieiri T; Yamamoto Y; Okamoto Y; Okabe H; Moro K; Shigeta M; Yoshida H; Yamashita M; Hida Y; Takubo T; Kusakabe T; Masaki H; Heijyou H; Nakaya H; Kawahara K; Sano R; Matsuo S; Kono H; Yuzuki Y; Ikeda N; Idomuki M; Soma M; Yamamoto G; Kinoshita S; Kawano S; Oka M; Kusano N; Kang D; Ono J; Yasujima M; Miki M; Hayashi M; Okubo S; Toyoshima S; Kaku M; Sekine I; Shiotani J; Horiuchi H; Tazawa Y; Yoneyama A; Kumasaka K; Koike K; Taniguchi N; Ozaki Y; Uchida T; Murakami M; Inuzuka K; Gonda H; Yamaguchi I; fujimoto Y; Iriyama J; Asano Y; Genma H; Maekawa M; Yoshimura H; Nakatani K; Baba H; Ichiyama S; Fujita S; Kuwabara M; Okazaki T; Fujiwara H; Ota H; Nagai A; Fujita J; Negayama K; Sugiura T; Kamioka M; Murase M; Yamane N; Nakasone I; Okayama A; Aoki Y; Kusaba K; Nakashima Y; Miyanohara H; Hiramatsu K; Saikawa T; Yanagihara K; Matsuda J; Kohno S; Mashiba K
    Jpn J Antibiot; 2009 Aug; 62(4):346-70. PubMed ID: 19860322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and bacteriological efficacies of sitafloxacin against community-acquired pneumonia caused by Streptococcus pneumoniae: nested cohort within a multicenter clinical trial.
    Fujita J; Niki Y; Kadota J; Yanagihara K; Kaku M; Watanabe A; Aoki N; Hori S; Tanigawara Y; Cash HL; Kohno S
    J Infect Chemother; 2013 Jun; 19(3):472-9. PubMed ID: 23179958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
    Fritsche TR; Sader HS; Cleeland R; Jones RN
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1468-76. PubMed ID: 15793128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Susceptibility of clinical isolates from primary care clinics to oral antibacterial agents].
    Fujimura T; Yoshida I; Yamano Y
    Jpn J Antibiot; 2007 Feb; 60(1):17-30. PubMed ID: 17436860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of 4903 bacterial isolates to gemifloxacin--an advanced fluoroquinolone.
    Blondeau JM; Hansen G; Metzler KL; Borsos S; Irvine LB; Blanco L
    Int J Antimicrob Agents; 2003 Aug; 22(2):147-54. PubMed ID: 12927955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae].
    Gidoh M
    Nihon Hansenbyo Gakkai Zasshi; 2007 Feb; 76(1):11-7. PubMed ID: 17315747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
    Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits.
    Tasaka Y; Suzuki T; Kawasaki S; Uda T; Mito T; Uno T; Ohashi Y
    J Ocul Pharmacol Ther; 2013 May; 29(4):403-9. PubMed ID: 23249386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2006)].
    Goto H; Takeda H; Kawai S; Suwabe A; Watanabe S; Okazaki M; Ashino Y; Shimada K; Aoki N; Sato T; Honma Y; Mori T; Kudo K; Sugiyama H; Kondo S; Tanaka T; Kido K; Yoshimura K; Oguri T; Yamamoto M; Nakamori Y; Inoue H; Yamauchi K; Sumitomo M; Endo S; Nakadate T; Oka M; Kobashi Y; Saita N; Yanagihara K; Kondou A; Matsuda J; Nakano M; Kohno S; Oikawa S
    Jpn J Antibiot; 2013 Dec; 66(6):331-55. PubMed ID: 24649798
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Eguchi H; Nishida K; Hotta F; Shimomura Y; Kusaka S
    J Ocul Pharmacol Ther; 2021 Mar; 37(2):84-89. PubMed ID: 33395563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.